Table 4 Odds ratios of having prescription drugs for males, compared to females, after adjustment for age, multi-morbidity and relevant prescription drug in univariate analyses (Model 2)
Prescription drug excluded from the analysis | OR (95% CI) | P-value |
|---|---|---|
NSAIDs | 0.44 (0.43-0.45) | <0.001 |
Buspirone | 0.45 (0.45-0.46) | <0.001 |
Coxibs | 0.45 (0.45-0.46) | <0.001 |
Inhalable corticosteroids | 0.45 (0.45-0.46) | <0.001 |
Ipratropium | 0.45 (0.45-0.46) | <0.001 |
Selective beta-2 stimulants | 0.45 (0.44-0.46) | <0.001 |
Antidepressants | 0.46 (0.45-0.47) | <0.001 |
Benzodiazepines | 0.46 (0.45-0.46) | <0.001 |
Benzodiazepine-related drugs | 0.46 (0.45-0.47) | <0.001 |
Derivatives of benzodiazepines | 0.46 (0.45-0.46) | <0.001 |
Hydroxyzine | 0.46 (0.45-0.46) | <0.001 |
Migraine drugs | 0.46 (0.45-0.47) | <0.001 |
Nitrofurantoin | 0.46 (0.45-0.47) | <0.001 |
Paracetamol | 0.46 (0.45-0.47) | <0.001 |
Propiomazine | 0.46 (0.45-0.46) | <0.001 |
Trimethoprim | 0.46 (0.45-0.47) | <0.001 |
Estrogens | 0.47 (0.46-0.48) | <0.001 |
Gestagens | 0.47 (0.46-0.48) | <0.001 |
Pivmecillinam | 0.47 (0.46-0.48) | <0.001 |
Thyroid hormones | 0.47 (0.46-0.48) | <0.001 |
Anti-conception drugs | 0.65 (0.64-0.66) | <0.001 |